![]() |
![]() |
|||
![]() |
Welcome to Our February Newsletter. This edition features news from the American Academy of Cosmetic Surgery Annual Meeting held last month in Phoenix, AZ Former Cosmetic Surgery Center Fellow Elected President of American Academy of Cosmetic Surgery
Guest Speaker at Academy Meeting outlines history of Cosmetic Surgery and the Challenges Facing the Specialty Dr. Gaylon McCollough of Gulf Shores, AL gave an excellent talk about the history of the specialty of Cosmetic Surgery. He emphasized the conflict that has continue regarding the claims of many groups as to who is most qualified to carry out cosmetic surgical procedures, pointing out that many fields have contributed to the specialty. Dr. McCollough shared his philosophy regarding the future of the cosmetic surgery profession. He emphasized the difference between cosmetic surgery and the newer nonsurgical procedures being touted. He felt that "surgeons should not be promoting or conducting nonsurgical procedures," emphasizing that injectable treatments do not qualify as surgical procedures. His theme, decidedly, hung around the notion that it is counterproductive for surgical groups to perform nonsurgical procedures. While, in principal, we agree with Dr. McCullough’s basic tenant that injectables do not qualify as surgical procedures, we do feel that they are a valuable adjunct that deserve a place in a Cosmetic Surgery practice. However, we also agree that, as surgeons, our primary emphasis remains on the core surgical practice upon which our Center was developed. Another theme in his talk was the matter of using unproven technology on patients. Investigate the effectiveness and efficacy of new technology and products you use, he said, and physicians need to be confident enough to use that new technology on his or her own family if they plan to use it in their practice. "It takes 5 to 7 years for new technology to be proven..." In this regard, we fully agree. Far too many inexperienced surgeons return from meetings and seminars to try new and unproven procedures. While we are always looking for improvements, it remains a fact that many, if not most, of the new ideas presented in journals and meetings do not pan out in the long run. Nothing ever replaces experience. FDA Reports Possible Link of Breast Implants to Rare Type of Cancer The U.S. Food and Drug Administration (FDA) has reported a possible link between breast implants and a rare type of cancer called anaplastic large-cell lymphoma (ALCL). 34 cases of the tumor in women with breast implants have been reported. This is a tiny proportion of the five to ten million women who have had implants. Most of the cases have involved silicone gel implants but seven cases have involved women with saline implants.
The tumor usually shows itself by the development of a fluid build up outside the implant. Because of this, patients who develop unusual swelling or fluid buildup should have it investigated. The evidence suggests that the kind of ALCL found in conjunction with breast implants is less aggressive and is sometimes treatable by simply removing the implant, the capsule, and collected fluid. The agency is advising women with breast implants not to change their routine medical care and follow-up. Because the risk for ALCL appears to be very small, the agency believes the weight of evidence "supports a reasonable assurance that FDA-approved breast implants are safe and effective when used as labeled." The FDA believes that women with breast implants may have an increased risk of developing ALCL, but also believes any potential risk is extremely low. Due to the rarity of ALCL, the small number of reports, and the incomplete and limited data from these reports, more information is needed to fully understand the possible link between breast implants and ALCL. Further information is available by following this link to the FDA’s report: FDA report Cosmetic Surgery continues to gain popularity for a number of reasons: 1. Positive change 2. Easily accessible 3. Less risk 4. More Options 5. Widely accepted Infection Prevention Program Updated at The Center Infection prevention is a top priority for the entire staff of the Facial Plastic & Cosmetic Surgical Center. We strive to provide the best and safest surgical environment for our patients. The number one way to accomplish this is by preventing problems before they occur. We. at the Center, value you as a patient and are confident that we have been doing everything in our power to make your surgical experience a positive one. This ongoing training will simply be a constant reminder of why things have to be done a certain way. All of this is to help to reinforce the importance of patient safety. If you have any questions regarding our policies or procedures, we will be happy to discuss them you. Surgery under the Fellowship Training Program The Facial Plastic & Cosmetic Surgical Center is an approved training center for both the American Academy of Cosmetic Surgery and the American Board of Cosmetic Surgery. Post Graduate Surgical Fellows spend a year of training at the Center. They are fully licensed in the state of Texas. As their training progresses, Fellows can take on responsibility as primary surgeon for selected patients who choose to have their surgery done under this program. Financial considerations are offered to patients who wish to have surgery done by the Fellows. The reduced fee for the procedure goes into the West Texas Foundation for Surgical Research and Education. It should be emphasized that unless these arrangements have been made in advance, the Fellow’s role in surgery is as an assistant and Dr. Tobin is the primary surgeon. The Fellow performs no primary surgery without the specific request of the patient. Patients who are interested in considering having their procedure done under the Fellowship program should inform the staff when scheduling their appointment. Depending on the circumstances, they may be seen initially by Dr. Tobin or by the Fellow, but will always have the opportunity to discuss their interest in surgery with Dr. Tobin before scheduling. If the patient, after consulting with the Fellow, feels comfortable with the Fellow taking responsibility for their care, they can proceed with scheduling the surgery. On the other hand, in some cases, after consulting with the Fellow, patients may choose not to have their surgery done by the Fellow, but rather by Dr. Tobin. This is fully recognized by the Fellows who understand that not every patient who considers the program ends up participating. That’s it for this edition. As always, your suggestions and comments are always welcome. Sincerely, Howard A. Tobin, M.D., F. A. C. S. For general information: askdena@newlook.org or n41gt@newlook.org The Facial Plastic & Cosmetic Surgical Center |
|||
|
||||
| To unsubscribe, please click here. | ||||
|
|
||||